Xun Shi

Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer

Chen Lin, Xun Shi, Yang Shao et al. · Lung Cancer · 2019 · 96 citations

Medicine, Cancer Biology, Oncology +11

Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas

Ying Jin, Xun Shi, Jun Zhao et al. · Lung Cancer · 2018 · 68 citations

Medicine, Oncology, Pharmacology +16

Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation

Ying Jin, Hua Bao, Xiuning Le et al. · Oncogene · 2019 · 62 citations

Medicine, Genetics, Oncology +17

Salvage treatment with apatinib for advanced non-small-cell lung cancer

Zhengbo Song, Xinmin Yu, Guangyuan Lou et al. · OncoTargets and Therapy · 2017 · 60 citations · Full text

Medicine, Oncology, Pharmacology +17

Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study

Yanjun Xu, Zhiyu Huang, Hongyang Lu et al. · British Journal of Cancer · 2019 · 57 citations · Full text

Medicine, Oncology, Pharmacology +16